>P16050_Disorder
81-92, 104-120, 320-336, 415-424, 438-451, 555-568
mglyrirvst gaslyagsnn qvqlwlvgqh geaalgkrlw pargketelk vevpeylgpl lfvklrkrhl lkddawfcnw ISVQGPGAGD EVrfpcyrwv egnGVLSLPE GTGRTVGEDP qglfqkhree eleerrklyr wgnwkdglil nmagaklydl pvderfledk rvdfevslak gladlaikds lnvltcwkdl ddfnrifwcg qsklaervrd swkedalfgy qflnganpvv lrrsahlpar lvfppgmeel qaqlekeleg gtlfeadfsl ldgikanvil csqqhlaapl vmlklqpdgk llpmviqlqL PRTGSPPPPL FLPTDPpmaw llakcwvrss dfqlhelqsh llrghlmaev ivvatmrclp sihpifklii phlrytlein vrartglvsd mgifDQIMST GGGGhvqllk qagafltYSS FCPPDDLADR Gllgvkssfy aqdalrlwei iyryvegivs lhyktdvavk ddpelqtwcr eiteiglqga qdrgfpvslq ardqvchfvt mciftctgqh asvhlgqldw yswvPNAPCT MRLPPPTTkd atletvmatl pnfhqaslqm sitwqlgrrq pvmvavgqhe eeyfsgpepk avlkkfreel aaldkeieir nakldmpyey lrpsvvensv ai
>P16050_GlobDoms
2-103, 121-319, 337-437, 452-554, 569-662
mGLYRIRVST GASLYAGSNN QVQLWLVGQH GEAALGKRLW PARGKETELK VEVPEYLGPL LFVKLRKRHL LKDDAWFCNW ISVQGPGAGD EVRFPCYRWV EGNgvlslpe gtgrtvgedp QGLFQKHREE ELEERRKLYR WGNWKDGLIL NMAGAKLYDL PVDERFLEDK RVDFEVSLAK GLADLAIKDS LNVLTCWKDL DDFNRIFWCG QSKLAERVRD SWKEDALFGY QFLNGANPVV LRRSAHLPAR LVFPPGMEEL QAQLEKELEG GTLFEADFSL LDGIKANVIL CSQQHLAAPL VMLKLQPDGK LLPMVIQLQl prtgsppppl flptdpPMAW LLAKCWVRSS DFQLHELQSH LLRGHLMAEV IVVATMRCLP SIHPIFKLII PHLRYTLEIN VRARTGLVSD MGIFDQIMST GGGGHVQLLK QAGAFLTyss fcppddladr gLLGVKSSFY AQDALRLWEI IYRYVEGIVS LHYKTDVAVK DDPELQTWCR EITEIGLQGA QDRGFPVSLQ ARDQVCHFVT MCIFTCTGQH ASVHLGQLDW YSWVpnapct mrlpppttKD ATLETVMATL PNFHQASLQM SITWQLGRRQ PVMVAVGQHE EEYFSGPEPK AVLKKFREEL AALDKEIEIR NAKLDMPYEY LRPSVVENSV AI
JOB-ID: | P16050_181251ZunGo38AAAEAAHvu4-oAAACC |
---|---|
Paramters: | propensities=Russell/Linding smooth=10 dy/dx_smooth=10 |
Disorder frames: | peak-frame=5 join-frame=4 |
Globularity frames: | peak-frame=74 join-frame=15 |
Name: | P16050 |
Description: | sp|P16050|LOX15_HUMAN Polyunsaturated fatty acid lipoxygenase ALOX15 OS=Homo sapiens OX=9606 GN=ALOX15 PE=1 SV=3 |
Plot title/ID: | none |
Sequence length: | 662 |
Download Results | smoothed raw dydx |